TERT and breast cancer: Our findings show that the known driver mutations in the TERT promoter do not commonly occur in breast cancer, but TERT is frequently overexpressed in breast tumors and this altered expression is associated with mutations in the putative driver DHS (chr5:1325957-1328153).